Abstract
The production of currently available vectors derived from autonomous parvoviruses requires the expression of capsid proteins in trans, from helper sequences. Cotransfection of a helper plasmid always generates significant amounts of replication-competent virus (RCV) that can be reduced by the integration of helper sequences into a packaging cell line. Although stocks of minute virus of mice (MVM)-based vectors with no detectable RCV could be produced by transfection into packaging cells; the latter appear after one or two rounds of replication, precluding further amplification of the vector stock. Indeed, once RCVs become detectable, they are efficiently amplified and rapidly take over the culture. Theoretically RCV-free vector stocks could be produced if all homology between vector and helper DNA is eliminated, thus preventing homologous recombination. We constructed new vectors based on the structure of spontaneously occurring defective particles of MVM. Based on published observations related to the size of vectors and the sequence of the viral origin of replication, these vectors were modified by the insertion of foreign DNA sequences downstream of the transgene and by the introduction of a consensus NS-1 nick site near the origin of replication to optimize their production. In one of the vectors the inserted fragment of mouse genomic DNA had a synergistic effect with the modified origin of replication in increasing vector production.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Merchlinsky MJ, Tattersall PJ, Leary JJ, Cotmore SF, Gardiner EM, Ward DC . Construction of an infective molecular clone of the autonomous parvovirus minute virus of mice J Virol 1983 47: 227–232
Astell CR, Gardiner EM, Tattersall P . DNA sequence of the lymphotropic variant of minute virus of mice, MVM(i), and comparison with the DNA sequence of the fibrotropic prototype strain J Virol 1986 57: 656–669
Nuesch JP, Tattersall P . Nuclear targeting of the parvoviral replicator molecule NS1: evidence for self-association prior to nuclear transport Virology 1993 196: 637–651
Brandenburger A, Legendre D, Avalosse B, Rommelaere J . NS-1 and NS-2 proteins may act synergistically in the cytopathogenicity of parvovirus MVM(p) J Virol 1990 174: 576–584
Caillet-Fauquet P, Perros M, Brandenburger A, Spegelaere P, Romemlaere J . Programmed killing of human cells by means of an inducible clone of parvoviral genes encoding non-structural proteins EMBO J 1990 9: 2989–2995
Tullis GE, Labieniec-Pintel L, Clemens KE, Pintel D . Generation and characterization of a temperature-sensitive mutation in the NS-1 gene of the autonomous parvovirus minute virus of mice J Virol 1988 62: 2736–2744
Cotmore SF, Tattersall P . DNA replication in the autonomous parvoviruses Semin Virol 1995 6: 271–281
Vanacker J-M, Rommeleare J . Non-structural proteins of autonomous parvoviruses: from cellular effects to molecular mechanisms Semin Virol 1995 6: 291–297
Lorson C, Burger LR, Mouw M, Pintel DJ . Efficient transactivation of the minute virus of mice P38 promoter requires upstream binding of NS1 J Virol 1996 70: 834–842
Lorson C, Pearson J, Burger L, Pintel DJ . An SP1-binding site and TATA element are sufficient to support full transactivation by proximally bound NS1 protein of minute virus of mice Virology 1998 240: 326–337
Corbeau R, Duverger V, Rommeleare J, Nuesch JP . Regulation of MVM NS1 by protein kinase C: impact of mutagenesis at consensus phosphorylation sites on replicative functions and cytopathic effects Virology 2000 278: 151–167
Nuesch JP, Christensen J, Rommeleare J . Initiation of minute virus of mice DNA replication is regulated at the level of origin unwinding by atypical protein kinase C phosphorylation of NS1 J Virol 2001 75: 5730–5739
Cziepluch C, Lampel S, Grewenig A, Grund C, Lichter P, Rommelaere J . H-1 parvovirus-associated replication bodies: a distinct virus-induced nuclear structure J Virol 2000 74: 4807–4815
Bashir T, Rommeleare J, Cziepluch C . In vivo accumulation of cyclin A and cellular replication factors in autonomous parvovirus minute virus of mice-associated replication bodies J Virol 2001 75: 4394–4398
Astell CR, Liu G, Brunstein J, Jindal HK, Tam P . Minute virus of mice cis-acting sequences required for genome replication and the role of the trans-acting viral protein NS1 Prog Nucleic Acid Res Mol Biol 1996 55: 245–285
Salvino R, Skiadopoulos M, Faust EA, Tam P, Shade OR, Astell CR . Two spatially distinct genetic elements constitute a bipartite DNA replication origin in the minute virus of mice genome J Virol 1991 65: 1352–1363
Faust EA, Ward D . Incomplete genomes of the parvovirus minute virus of mice selective conservation of genome termini, including the origin for DNA replication J Virol 1979 32: 276–292
Christensen J, Cotmore SF, Tattersall P . Minute virus of mice initiator protein NS1 and a host KDWK family transcription factor must form a precise ternary complex with origin DNA for nicking to occur J Virol 2001 75: 7009–7017
Cotmore SF, Christensen J, Tattersall P . Two widely spaced initiator binding sites create an HMG1-dependent parvovirus rolling-hairpin replication origin J Virol 2000 74: 1332–1341
Clément N, Avalosse B, El Bakkouri K, Velu T, Brandenburg A . Cloning and sequencing of defective particles derived from the autonomous parvovirus Minute Virus of Mice for the construction of vectors with minimal cis-acting sequences J Virol 2001 75: 1284–1293
Dupont F, Karim A, Dumon JC, Mine N, Avalosse B . A novel MVMp-based vector system specifically designed to reduce the risk of replication-competent virus generation by homologous recombination Gene Ther 2001 8: 921–929
Brandenburger A, Coessens E, El Bakkouri K, Velu T . Influence of sequence and size of DNA on packaging efficiency of parvovirus MVM-based vectors Hum Gene Ther 1999 10: 1229–1238
Kestler J, Neeb B, Struyf S et al. Cis requirements for the efficient production of recombinant DNA vectors based on autonomous parvoviruses Hum Gene Ther 1999 10: 1619–1632
Russell SJ, Brandenburger A, Flemming CL, Collins MK, Rommelaere J . Transformation-dependent expression of interleukin genes delivered by a recombinant parvovirus J Virol 1992 66: 2821–2828
Leach D . Cloning and characterization of DNAs with palindromic sequences Genet Eng (NY) 1996 18: 1–11
El Bakkouri K, Clément N, Velu T, Brandenburger A . Amplification of MVM(p) vectors through serial infection of a new packaging cell line Tumor Target 2000 4: 210–217
Tam P, Astell CR . Replication of minute virus of mice minigenomes: novel replication elements required for MVM DNA replication Virology 1993 193: 812–814
Cossons N, Zannis-Hadjopoulos M, Tam P, Astell CR, Faust EA . The effect of regulatory sequence elements upon the initiation of DNA replication of the minute virus of mice Virology 1996 224: 320–325
Bloss TA, Sudgen B . Optimal lengths for DNAs encapsidated by Epstein-Barr virus J Virol 1994 68: 8217–8222
Dong J-Y, Fan P-D, Frizell RA . Quantitative analysis of the packaging capacity of recombinant adeno-associated virus Hum Gene Ther 1996 7: 2101–2112
Alemany R, Dai Y, Lou YC et al. Complementation of helper-dependent adenoviral vectors: size effects and titer fluctuations J Virol Methods 1997 68: 147–159
Schoborg RV, Pintel DJ . Accumulation of MVM gene products is differentially regulated by transcription initiation, RNA processing and protein stability Virology 1991 181: 22–34
Mitchell P, Tollervey D . mRNA stability in eucaryotes Curr Opin Genet Dev 2000 10: 193–198
Acknowledgements
N Clément was supported by a grant from the FNRS/Télévie. This work was subsidized by a grant from the “Fédération contre le Cancer” from the Grand Duchy of Luxembourg. We also benefited from support by “FEDER” in the framework of the program “Hainaut-Nord-Pas de Calais-Picardie” and the Association Française contre les Myopathies (AFM). AB would like to thank the Fondation Lions “Vaincre le Cancer” (Grand Duchy of Luxembourg) for their support.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Clément, N., Velu, T. & Brandenburger, A. Construction and production of oncotropic vectors, derived from MVM(p), that share reduced sequence homology with helper plasmids. Cancer Gene Ther 9, 762–770 (2002). https://doi.org/10.1038/sj.cgt.7700496
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.cgt.7700496